Skip to main content
Article thumbnail
Location of Repository

Factors Influencing International Normalized Ratio in Patients Anticoagulated With Warfarin(Special Issue in Hornor of the Retirement of Professor Makoto Iwata at the Department of Neurology, Tokyo Women's Medical University)

By  洋美 赫,  真一郎 内山 and  誠 岩田


Preventive effect of warfarin for the development of cardiogenic embolism is well established. However, variability in the required dose for each individual makes it difficult to prescribe adequate dose of warfarin because of the potential risk of hemorrhage. In the present study, we retrospectively evaluated relationship between the international normalized ratio (INR) and several patient-specific clinical factors such as gender, age, body weight, patient's medical status, risk factors for stroke, renal/liver function, and hemostatic markers. Eighty-six patients (55: men, 31: women, mean age of 68 years) anticoagulated with oral warfarin between April 2004 and March 2006 were entered in the study. Among patient-specific factors, we analysed factors influencing INR during warfarin therapy. Under warfarin treatment, three factors were associated with increased INR/mg ratio; body weight<40 kg, coagulopathy, and renal failure. In contrast, following factors decreased INR/mg ratio; age < 50 years, body weight &ge;80 kg, and increased levels of platelet activation markers

Topics: Warfarin, international normalized ratio, stroke prevention
Publisher: 東京女子医科大学学会
Year: 2008
OAI identifier:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.